Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents distinct cancer subtypes
    Meeting Abstract

    Schmid, P.; Kowanetz, M.; Koeppen, H.; Zou, W.; Wistuba, I.; Kockx, M.; Kadel, E. E.; Chaft, J.; Rizvi, N. A.; Hirsch, F. R.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement
    Meeting Abstract

    Varga, A.; Camidge, D. R.; Sequist, L. V.; Wakelee, H.; Ou, S. H.; Goldman, J. W.; Papadimitrakopoulou, V.; Gadgeel, S.; Mekhail, T.; Oxnard, G. R.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Outcomes of well-differentiated papillary peritoneal mesothelioma
    Meeting Abstract

    Nash, G.; Morris, M.; Krug, L.; Zauderer, M.; Rusch, V.; Cercek, A.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Pneumonitis with anti-PD-1/PD-L1 therapy
    Meeting Abstract

    Naidoo, J.; Cunningham, J.; Woo, K. M.; Hellmann, M. D.; Postow, M. A.; Drilon, A. E.; Chaft, J. E.; Lesokhin, A. M.; Segal, N. H.; Callahan, M. K.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Lurbinectedin (PM01183) in combination with paclitaxel (P) in patients (pts) with advanced solid tumors
    Meeting Abstract

    Garralda, E.; Stathis, A.; Drilon, A.; Boni, V.; Hyman, D.; Calvo, E.; Griguolo, G.; Makker, V.; Doger, B.; Canziani, L.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors
    Journal Article

    Davare, M. A.; Vellore, N. A.; Wagner, J. P.; Eide, C. A.; Goodman, J. R.; Drilon, A.; Deininger, M. W.; O'Hare, T.; Druker, B. J.
    Proceedings of the National Academy of Sciences of the United States of America (2015)

    Fulltext@MSK | Save
  • Preliminary safety, pharmacokinetics, and efficacy of regorafenib, cisplatin, and pemetrexed in patients with advanced nonsquamous non-small-cell lung cancers
    Journal Article

    Hellmann, M. D.; Sturm, I.; Trnkova, Z. J.; Lettieri, J.; Diefenbach, K.; Rizvi, N. A.; Gettinger, S. N.
    Clinical Lung Cancer (2015)

    Fulltext@MSK | Save
  • Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other genomic testing approaches
    Journal Article

    Drilon, A.; Wang, L.; Arcila, M. E.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; Kris, M. G.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
    Journal Article

    Saunders, L. R.; Bankovich, A. J.; Anderson, W. C.; Aujay, M. A.; Bheddah, S.; Black, K.; Desai, R.; Escarpe, P. A.; Hampl, J.; Laysang, A.; more...
    Science Translational Medicine (2015)

    Fulltext@MSK | Save
  • ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma
    Journal Article

    Hutchinson, K. E.; Johnson, D. B.; Johnson, A. S.; Sánchez, V.; Kuba, M.; Lu, P.; Chen, X.; Kelley, M. C.; Wang, Q.; Zhao, Z.; more...
    Oncotarget (2015)

    Fulltext@MSK | Save